Assessment and Management of the Heightened Risk for Atherosclerotic Cardiovascular Events in Patients with Lupus Erythematosus or Dermatomyositis
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Women's Dermatology"
DOI: 10.1016/j.ijwd.2021.08.015
Abstract: Abstract For patients with lupus erythematosus (LE) or dermatomyositis (DM), there is an urgent need to address their heightened risk of clinical events, chiefly heart attacks and strokes, caused by atherosclerotic cardiovascular disease (ASCVD). Patients… read more here.
Keywords: heightened risk; risk; lupus erythematosus; patients lupus ... See more keywords
Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women
Sign Up to like & getrecommendations! Published in 2021 at "Heart"
DOI: 10.1136/heartjnl-2020-318764
Abstract: Objective We investigated whether the evaluation of bone mineral density (BMD) provides independent and incremental prognostic value for predicting atherosclerotic cardiovascular disease (ASCVD) in women. Methods A total of 12 681 women aged 50–80 years… read more here.
Keywords: risk; bone mineral; prognostic value; bmd ... See more keywords
Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
Sign Up to like & getrecommendations! Published in 2022 at "PLOS ONE"
DOI: 10.1371/journal.pone.0276898
Abstract: Background and aims The LDL cholesterol (LDL-C) treatment goals recommended by the 2019 ESC/EAS guidelines are only achieved in a minority of patients. The study objective was to estimate the impact of bempedoic acid treatment… read more here.
Keywords: bempedoic acid; risk; ascvd events; treatment ... See more keywords